Merck & Co Extend Association with Moderna on New Oncology Programme
By Keshav Mahawar
Pharma Deals Review: Vol 2016 Issue 7 (Table of Contents)
Published: 26 Jul-2016
DOI: 10.3833/pdr.v2016.i7.2175 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Merck has expanded its research collaboration with Moderna Therapeutics and paid US$200 M upfront to license, develop and commercialise its messenger RNA (mRNA)-based novel technology...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS